Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P41
Within normal range
vs 2Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -67.92% |
| Q3 2025 | 209.09% |
| Q2 2025 | -210.00% |
| Q1 2025 | -71.43% |
| Q4 2024 | 111.25% |
| Q3 2024 | -858.54% |
| Q2 2024 | 115.79% |
| Q1 2024 | -64.53% |
| Q4 2023 | 132.87% |
| Q3 2023 | -58.93% |
| Q2 2023 | 230.23% |
| Q1 2023 | -95.45% |
| Q4 2022 | -1000.00% |
| Q3 2022 | -104.55% |
| Q2 2022 | 193.33% |
| Q1 2022 | 225.00% |
| Q4 2021 | -130.00% |
| Q3 2021 | -6.98% |
| Q2 2021 | 79.17% |
| Q1 2021 | -27.27% |
| Q4 2020 | -89.11% |
| Q3 2020 | 1882.35% |
| Q2 2020 | -189.47% |
| Q1 2020 | 258.33% |
| Q4 2019 | 20.00% |
| Q3 2019 | -314.29% |
| Q2 2019 | 200.00% |
| Q1 2019 | -135.00% |
| Q4 2018 | 1382.05% |
| Q3 2018 | -126.00% |
| Q2 2018 | 123.08% |
| Q1 2018 | -336.36% |
| Q4 2017 | 157.89% |
| Q3 2017 | 61.22% |
| Q2 2017 | 5.77% |
| Q1 2017 | -372.73% |
| Q4 2016 | 81.36% |
| Q3 2016 | -180.95% |
| Q2 2016 | -110.00% |
| Q1 2016 | -47.28% |